Seeing the unseen dynamics of molecules, shaping the future of medicine

molmir Inc. is a biotech startup originated from Nara Medical University, AIST, and Tokushima University.
We have developed a unique technology that allows us to observe the dynamics of molecules—how they move and interact—based on our research into a phenomenon called phase separation that occurs in living cells.
With this technology, molecules that constantly change shape—previously impossible to target with conventional drug development—can now become candidates for new medicines.
We are using this approach to explore new possibilities for treating diseases such as ALS (amyotrophic lateral sclerosis), Alzheimer’s, cancer, and heart disease—conditions for which effective treatments are still lacking.
The name “molmir” comes from combining “molecule” and the Japanese word “miru” (to see).
By observing the dynamics of molecules, we aim to create new medicines that protect people’s health and shape the future of medical care.

Venture from Academia（3 institutional accreditations）

molmir, Inc. is a startup certified by Nara Medical University, National Institute of Advanced Industrial Science and Technology, AIST, and Tokushima University. They were registered as accredited ventures in June 2022 (No. 5), July 2022 (No. 153), and August 2022 (No. 31), respectively. In the future, we will continue to cooperate with various research institutes and aim to stand as a “human resource platform (infrastructure/receptacle) for Japanese science and technology”.

A member list（January 13, 2023）

Eiichiro Mori    （CEO・Nara Medical University）
Masataka Yamamoto（COO）
Kota Togami      （CFO）
Shunsuke Tomita  （Scientific Advisor・AIST）
Tomohide Saio    （Scientific Advisor・Tokushima University）

News